Author

A. Basak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. Gabba· 1 shared A. Ghosh· 1 shared A. K. Das· 1 shared A. K. Shalek· 1 shared A. Mondal· 1 shared A. R. McGill· 1 shared A. Roy· 1 shared B. Chandran· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Gabba

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Glycan-costumed virus-like particles promote type 1 anti-tumor immunity

V. Lensch, A. Gabba, R. Hincapie, S. H. Bhagchandani, A. Basak, M. M. Alam, D. J. Irvine, A. K. Shalek, J. A. Johnson, M. G. Finn, L. L. Kiessling

This study develops glycan-costumed virus-like particles that activate dendritic cells and induce type 1 anti-tumor immunity in a murine model.

bioRxiv · Jan 18, 2024 · PreprintBiochemistry

Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2

I. D. Jana, P. Bhttacharya, K. Mayilsamy, S. Banerjee, G. Bhattacharje, S. Das, S. Aditya, A. Ghosh, A. R. McGill, S. Srikrishnan, A. K. Das, A. Basak, S. S. Mohapatra, B. Chandran, D. Bhimsaria, , A. Mondal

This study identifies an evolutionarily conserved 'E-L-L' motif in the SARS-CoV-2 spike protein as a target for small molecule fusion inhibitors, showing posaconazole effectively blocks viral entry across variants.

bioRxiv · Mar 16, 2022Biochemistry